Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(3.69)
# 2,085
Out of 5,189 analysts
10
Total ratings
90%
Success rate
23.5%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Initiated Coverage: Sell | $1,200 | $1,666.88 | -28.01% | 1 | Sep 2, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €285.00 | €288.00 | -1.04% | 1 | Apr 17, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 | $133.72 | +33.86% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $163.81 | -2.33% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $575 → $620 | $669.54 | -7.40% | 2 | Apr 17, 2026 | |
| BRKR Bruker | Reiterated: Buy | $60 | $56.46 | n/a | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $170.38 | n/a | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $440.45 | n/a | 1 | Oct 8, 2025 |
Mettler-Toledo International
Sep 2, 2026
Initiated Coverage: Sell
Price Target: $1,200
Current: $1,666.88
Upside: -28.01%
Sartorius Aktiengesellschaft
Apr 17, 2026
Reiterated: Buy
Price Target: €285.00
Current: €288.00
Upside: -1.04%
Merck & Co.
Apr 17, 2026
Reiterated: Buy
Price Target: $179
Current: $133.72
Upside: +33.86%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $163.81
Upside: -2.33%
Thermo Fisher Scientific
Apr 17, 2026
Reiterated: Buy
Price Target: $575 → $620
Current: $669.54
Upside: -7.40%
Bruker
Nov 20, 2025
Reiterated: Buy
Price Target: $60
Current: $56.46
Upside: n/a
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $170.38
Upside: n/a
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $440.45
Upside: n/a